Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA-001 )

NCT ID: NCT06335108

Last Updated: 2026-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

349 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-05

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study aims to investigate the impact of Tumescent Local Anesthesia (TLA) on pain perception following surgeries typical for breast cancer. Previous research has already confirmed the feasibility of conducting operations in TLA for benign breast conditions. In contrast to general anesthesia, Tumescent Local Anesthesia involves local anesthesia of the surgical site, allowing patients to remain awake during the procedure and eliminating the risks associated with general anesthesia. Additionally, if needed, sedatives or further anesthesia can be administered through the vein. Building upon the successful applications of TLA in benign breast surgeries, this follow-up study at the Department of Women's Health focuses on enhancing surgical techniques, pain management, and postoperative care for breast cancer-related procedures. Simultaneously, our goal is to gather scientific data regarding the application of this technique. This research contributes to the continuous advancement of medical practices in the field of breast surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Carcinoma Breast Carcinoma in Situ

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

Surgery carried out according to clinical routine under general anaesthesia.

General Anaesthesia

Intervention Type PROCEDURE

Breast surgery is carried out under general anesthesia.

Local Anaesthesia Group

Surgery carried out under local tumescent anaesthesia. Procedure

Local tumescent anaesthesia

Intervention Type PROCEDURE

Breast surgery is carried out under local tumescent anesthesia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

General Anaesthesia

Breast surgery is carried out under general anesthesia.

Intervention Type PROCEDURE

Local tumescent anaesthesia

Breast surgery is carried out under local tumescent anesthesia.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Written informed consent
* Histologically confirmed breast carcinoma or pure ductal carcinoma in situ
* Planned operation:
* Segmental resection/ breast-conserving surgery
* Segmental resection/ breast-conserving surgery with SNB
* Ablatio
* Ablatio with SNB/ axilla exploration

Exclusion Criteria

* Expected lack of patient compliance or inability of the patient to understand the purpose of the study
* Lack of patient consent
* Pregnancy
* Complete axillary dissection
* Tumour-adapted reduction surgery, implant reconstructions
* Surgeries where technical difficulties are expected under any anaesthesia (e.g. ASA IV, BMI \> 40)
* Bilateral breast operations
* Men


* Injection phobia
* Psychoses/ previous psychological illnesses
* Advanced dementia
* Language barrier
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Tuebingen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bettina Böer, Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Tübingen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Women's Hospital

Tübingen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SenoEx_TLA_Maligne

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain After Breast Surgery
NCT03307525 COMPLETED